<  Back to the Polytechnique Montréal portal

Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial

Laura Orlando, Evaristo Maiello, Michele Orditura, Anna Diana, Giuliano Antoniol, Maria Grazia Morritti, Michele Aieta, Mariangela Ciccarese, Salvatore Pisconti, Roberto Bordonaro, Antonio Russo, Antonio Febbraro, Paola Schiavone, Annamaria Quaranta, Chiara Caliolo, Dario Loparco, Margherita Cinefra, Giuseppe Colucci and Saverio Cinieri

Article (2024)

Open Acess document at official publisher
An external link is available for this item
Department: Department of Computer Engineering and Software Engineering
PolyPublie URL: https://publications.polymtl.ca/58098/
Journal Title: The Breast (vol. 75)
Publisher: Elsevier
DOI: 10.1016/j.breast.2024.103725
Official URL: https://doi.org/10.1016/j.breast.2024.103725
Date Deposited: 30 Apr 2024 12:41
Last Modified: 30 Apr 2024 12:41
Cite in APA 7: Orlando, L., Maiello, E., Orditura, M., Diana, A., Antoniol, G., Morritti, M. G., Aieta, M., Ciccarese, M., Pisconti, S., Bordonaro, R., Russo, A., Febbraro, A., Schiavone, P., Quaranta, A., Caliolo, C., Loparco, D., Cinefra, M., Colucci, G., & Cinieri, S. (2024). Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial. The Breast, 75, 103725-103725. https://doi.org/10.1016/j.breast.2024.103725

Statistics

Dimensions

Repository Staff Only

View Item View Item